Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: A double-blinded randomised dietary intervention trial

British Journal of Nutrition

Volumn 111, Issue 11, 2014, Pages 1992-1999

  Sofi, Francesco ^a,b,c,d   Whittaker, Anne ^d   Gori, Anna Maria ^b,c   Cesari, Francesca ^b   Surrenti, Elisabetta ^a   Abbate, Rosanna ^b,d   Gensini, Gian Franco ^b,c   Benedettelli, Stefano ^d   Casini, Alessandro ^a,b,d  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cytokines; Diets; Grains; Irritable bowel syndrome; Wheat

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; CCL2 PROTEIN, HUMAN; IFNG PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BISCUIT; BLOATING; BLOOD ANALYSIS; BREAD; CLINICAL ARTICLE; CONTROLLED STUDY; CRACKER; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FECES COMPOSITION; FEMALE; FOOD; FOOD INTAKE; HUMAN; INTERVENTION STUDY; IRRITABLE COLON; MALE; PASTA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRITICUM TURGIDUM; TRITICUM TURGIDUM SUBSPECIES TURANICUM; ADOLESCENT; AGED; BLOOD; BODY MASS; DIET; DIET THERAPY; MIDDLE AGED; QUESTIONNAIRE; WHEAT; YOUNG ADULT;

TRITICUM AESTIVUM; TRITICUM TURGIDUM;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHEMOKINE CCL2; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TRITICUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84900536983     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451400018X     Document Type: Article

References (22)

1. Ford AC & Talley NJ (2012) Irritable bowel syndrome. BMJ 345 e5836.
2. Camilleri M (2012) Periph eral mechanisms in irritable bowel syndrome. N Engl J Med 367 1626-1635.
3. Heizer WD Southern S & McGovern S (2009) The role of diet in symptoms of irritable bowel syndrome in adults: A narrative view. J Am Diet Assoc 109 1204-1214.
4. Sofi F Ghiselli L Cesari F et al. (2010 Effects of short-term consumption of bread obtained by an old Italian grain variety on lipid inflammatory an d hemorheological variables: An intervention study J Med Food 13 615-620.
5. Sofi F Whittaker A Cesari F et al. (2013) Characterization of Khorasan wheat (Kamut) and impact of a replacement diet on cardiovascular risk factors: Cross-over dietary intervention study. Eur J Clin Nutr 67 190-195.
6. Clarke G Quigley EM Cryan JF et al. (2009) Irritable bowel syndrome: Towards biomarker identification. Trends Mol Med 15 478-489.
7. Bashashati M Rezaei N Andrews CN et al. (2012) Cytokines and irritable bowel syndrome: where do we stand Cytokine 57 201-209.
8. Dinan TG Clarke G Quigley EM et al. (2008) Enhanced cholinergic-mediated increase in pro-inflammatory cytokine IL-6 in irritable bowel syndrome: Role of muscarinic receptors. Am J Gastroenterol 103 2570-2576.
9. Francis CY Morris J & Whorwell PJ (1997) The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 11 395-402.
10. Schoenfield P & Talley NJ (2006) Measuring successful treatment of irritable bowel syndrome: Is "satisfactory relief"enough Am J Gastroenterol 101 1066-1068.
11. Drisko J Bischoff B Hall M et al. (2006) Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr 25 514-522.
12. Biesiekierski JR Newnham ED Irving PM et al. (2011) Gluten causes gastrointestinal symptoms in subjects without celiac disease: A double blinded randomized placebocontrolled trial. Am J Gastroenterol 106 508-51 4.
13. O'Malley D Cryan JF & Dinan TG (2013) Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion. Brain Behav Immun 30 115-12 4.
14. Liebregts T Adam B Bredack C et al. (2007) Immune activation in patients with irritable bowel syndrome. Gastroenterology 132 913-920.
15. Scully P McKernan DP Keohane J et al. (2010) Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 105 2235-2243.
16. Spiller R Aziz Q Creed F et al. (2007) Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 56 1770-1798.
17. Lakhan SE & Kirchgessner A (2010) Gut inflammation in chronic fatigue syndrome. Nutr Metab (London) 7 79-88.
18. O'Mahony L McCarthy J Kelly P et al. (2005) Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 128 541-551.
19. Schmulson M Pulido-London D Rodriguez O et al. (2012) Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am J Gastroenterol 107 747-753.
20. Chiba T Sato K Toya Y et al. (2011) Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarophil. Hepatogastr oenterology 58 1527-1530.
21. Ivanov S & Lindén A (2009) Interleukin-17 as a drug target in human disease. Trends Pharmacol Sci 30 95-103.
22. Halpert A Dal ton CB Palsson O et al. (2007) What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 102 1972-1982.